Niagen Bioscience Inc (NAGE) vs Anbio Biotechnology Class A Ordinary Shares (NNNN)

A side-by-side comparison of Niagen Bioscience Inc and Anbio Biotechnology Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Niagen Bioscience Inc logo
NAGE
Niagen Bioscience Inc
$214M
$2.69HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Anbio Biotechnology Class A Ordinary Shares logo
NNNN
Anbio Biotechnology Class A Ordinary Shares
$211M
$4.80HealthcareDelayed quote: Oct 6, 2026, 2:48 PM EDT

Total return — NAGE vs NNNN

growth of $100 · dividends reinvested · last 2y
NAGE -51.1% (-30.1%/yr)NNNN -16.3% (-8.5%/yr)NNNN compounded faster over this window
0200400600800Start $1002026$49$84
NAGE NNNN

NAGE vs NNNN: by the numbers

  • •NAGE is the larger company ($214M vs $211M market cap).
  • •NNNN converts more revenue to profit (74.06% vs 12.39% net margin).

Metrics side by side

Valuation

MetricNAGENNNN
P/E ratio14.40N/A
Forward P/E18.62N/A
P/S ratio1.66N/A
P/B ratio2.596.99
EV / EBITDA14.32N/A
FCF yield2.65%N/A

Profitability

MetricNAGENNNN
Gross margin64.24%87.24%
Operating margin6.67%66.70%
Net margin12.39%74.06%
ROE19.38%21.24%
ROIC8.84%19.13%

Growth (annualized)

MetricNAGENNNN
Revenue CAGR (5Y)15.80%N/A
Total return CAGR (5Y)-15.72%N/A

Frequently asked

Is NAGE or NNNN more profitable?
NNNN runs the higher net margin — NAGE at 12.39% versus NNNN at 74.06%.

Go deeper

Full NAGE analysisFull NNNN analysisInteractive comparison tool

Dig into the metrics

Niagen Bioscience P/E ratioNiagen Bioscience ROEAnbio Biotechnology Class A Ordinary Shares ROENiagen Bioscience operating marginAnbio Biotechnology Class A Ordinary Shares operating marginNiagen Bioscience revenue growthAnbio Biotechnology Class A Ordinary Shares revenue growthNiagen Bioscience free cash flowAnbio Biotechnology Class A Ordinary Shares free cash flow

Niagen Bioscience & Anbio Biotechnology Class A Ordinary Shares appear in these rankings

Fastest Revenue Growth StocksHighest ROIC StocksHighest Operating Margin StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.